Gilead gonna get rich off Chi-na flu.

dwhee87

Senior Member
Gilead Sciences is already valued at 93 Billion. They aren't 'gonna' get rich.
 
For U.S. patients with commercial insurance, Gilead said it will charge $3,120 per course, or $520 per vial. That is a 33% increase over the $390 per vial Gilead said it will charge governments of developed countries and U.S. patients in government healthcare programs.
Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).
:pop:
 

dwhee87

Senior Member
I guess I need to plan a trip to India, and bring back a truckload to sell on Silk Road. ;)
 

Balrog

Senior Member
Seems like that is a lot cheaper than I would have thought. I just don't see how they will be able to pay all that kick back money to doctors at that price point...:rolleyes:
 
Top